{
  "id": 16056949,
  "title": "Commentary: Evonik must show that independence is more than just defence.",
  "url": "https://urgent.news/2026/10/22/kommentar-evonik-muss-zeigen-dass-eigenstandigkeit-mehr-ist-als-abwehr",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-22T14:20:05.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/meinung/kommentare/kommentar-evonik-muss-zeigen-dass-eigenstaendigkeit-mehr-ist-als-abwehr/100264173.html"
  },
  "original_language": "de",
  "account": "Evonik is facing pressure to demonstrate its attractiveness as an independent company following BASF's takeover bid. The company can no longer simply reject the offer, but must present its own plans. Evonik's planned acquisition of US chemical company Ashland provides an opportunity to do so, as it aligns with the company's growth strategy and shifts its focus to North America. However, Ashland's value has increased, and financial investors are interested, which may drive up the cost of the acquisition.",
  "summary": "The planned US acquisition strengthens Evonik's arguments against a takeover by BASF - but shows how expensive an independent growth strategy can be.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}